Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/21/2010US20100267740 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/21/2010US20100267736 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267735 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267734 N-[(3,5-dichlorophenyl)methyl]-2-(4-methyl-1-piperazinyl)-2-(1-naphthalenyl)ethanamide as ghrelin receptor modulator
10/21/2010US20100267733 Synergistic Modulation of Microglial Activation by Nicotine and THC
10/21/2010US20100267732 Prognostic Molecular Markers for ET-743 Treatment
10/21/2010US20100267731 Use of transforming growth factor-b receptor inhibitors to suppress ocular scarring
10/21/2010US20100267730 Novel compounds
10/21/2010US20100267728 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
10/21/2010US20100267727 Pharmaceutical formulations comprising neurotrophin mimetics
10/21/2010US20100267726 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267724 S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
10/21/2010US20100267723 Imidazole Substituted Pyrimidines
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267720 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate
10/21/2010US20100267719 Enhanced Indolinone Based Protein Kinase Inhibitors
10/21/2010US20100267718 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267716 Methods of treating inflammations and infections with pyridinium salts
10/21/2010US20100267715 Polymorph Form II of Tanaproget
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267713 4,4-disubstituted piperidines
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267709 Inhibitors of janus kinases
10/21/2010US20100267708 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
10/21/2010US20100267707 Tyrosine Kinase Inhibitors
10/21/2010US20100267706 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/21/2010US20100267705 Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267702 Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis
10/21/2010US20100267701 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
10/21/2010US20100267700 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
10/21/2010US20100267699 Chemical compounds - 643
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267695 Fused indane compound
10/21/2010US20100267694 S-mirtazapine for the treatment of hot flush
10/21/2010US20100267693 Orodispersible pharmaceutical composition of ivabradine
10/21/2010US20100267692 smac mimetic compounds as apoptosis inducers
10/21/2010US20100267691 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
10/21/2010US20100267690 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267687 Phenylpyrazole derivatives
10/21/2010US20100267686 Carbacephem beta-lactam antibiotics
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100267684 Use of biological surfactant as anti-inflammatory agent and tissue preservative solution
10/21/2010US20100267683 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field
10/21/2010US20100267682 Corticosteroids to treat epothilone or epothilone derivative induced diarrhea
10/21/2010US20100267681 Fat or oil composition
10/21/2010US20100267679 Pharmaceutical combination of medication to be used by patients for the purpose of preventing or reducing the evolution of atherosclerosis and thus preventing coronary heart disease and cerebro-vascular accidents.
10/21/2010US20100267678 Flux-enabling compositions and methods for dermal delivery of drugs
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267675 Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
10/21/2010US20100267674 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
10/21/2010US20100267673 Protein phosphatase 2a-activating agents
10/21/2010US20100267672 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267670 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267667 Telomerase activating compounds and methods of use thereof
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267665 Remedy for corneal diseases
10/21/2010US20100267664 Ophthalmic compositions containing polysaccharide-borate gelling system
10/21/2010US20100267663 A composition for cicatrisation processes in the treatment of hypertrophic scars and for improving the biomechanical properties of the cutis
10/21/2010US20100267662 Avenanthramide-containing compositions
10/21/2010US20100267661 Beta glucans and methods of use thereof
10/21/2010US20100267660 microorganism comprising a heterologous gene encoding a bifunctional Campylobacter jejuni sialytransferase polypeptide and which lacks Neu5Ac aldolase activity and beta galactosidase activity; treating Miller Fisher syndrome
10/21/2010US20100267659 Extract obtained from orchidaceae plants, method for producing the extract, and external agent for skin comprising the extract
10/21/2010US20100267658 Trehalulose-containing composition, its preparation and use
10/21/2010US20100267657 Antimetabolite agent combinations in the treatment of cancer
10/21/2010US20100267656 Myeloid differentiation inducing agents
10/21/2010US20100267655 Glycosylated Warfarin Analogs and Uses Thereof
10/21/2010US20100267654 Rifamycin derivatives
10/21/2010US20100267653 Use of coumarin derivatives in antifungal therapy
10/21/2010US20100267652 Method of inhibiting abcg2 and related treatments
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267645 Methods and compositions for treating ocular disease
10/21/2010US20100267643 Chemosensory Receptor Ligand-Based Therapies
10/21/2010US20100267640 Method of Attenuating Neurogenic Swelling or Neurogenic Inflammation
10/21/2010US20100267636 Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy
10/21/2010US20100267634 Anti-Viral Compounds
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267629 Enterostatin as Therapeutic Agent for Hypoglycemia
10/21/2010US20100267626 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267614 Prodrugs of Peripheral Phenolic Opioid Antagonists
10/21/2010US20100267611 Treatment of metabolic disease
10/21/2010US20100267146 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
10/21/2010US20100266716 Natural Photodynamic Agents and their use
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
1 ... 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 ... 7860